Global Precision Medicine Market to reach USD 96 Bn by 2024

The rising emphasis on targeted therapeutics has undoubtedly taken precision medicine market to brew a storm in the healthcare sector. Several healthcare experts are expecting precision medicine to completely bridge the gap between the potential and reality of delivering healthcare. For the record, precision medicine aims to treat diseases with special consideration for the individual’s biological variability. Industry analysts further state the increasing rate of cancer, tumors, and other chronic diseases to be pivotal factors demanding for more personalized treatments and practices that can be tailored according to individual variability in genes, lifestyles, and environment.

Precision medicine industry has been touted to be one of the paramount pillars of the future of healthcare, and stands to gain substantial remuneration in the ensuing years. A report compiled by Global Market Insights, Inc., state the worldwide precision medicine market to attain a valuation of USD 96 billion in coming seven years, expanding at a CAGR of 10.5% over 2017-2024.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/671

Underpinning the shift to value-based and patient-centric care in the healthcare sector, precision medicine is thriving as a novel treatment method that has gained a massive government and public backing. Citing an instance, back in January 2015, the former U.S. President Barack Obama, launched the Precision medicine initiative (PMI) to extend precision medicine approach for all diseases by building a research unit of nearly 1 million Americans. Now called as the All of Us program, the PMI was initiated to collect genetic and environmental information to create precision medicines.

Reportedly, the initiative received a government funding of USD 215 million, of which, USD 130 million was allocated to the National Institutes of Health for building national research unit and USD 70 million to National Cancer Institute to support the studies related to cancer genomics. According to a recent update on the PMI bulletin, the government is handing out over 10,000 Fitbits to the research institute to gain more insight into daily activities. Industry analysts predict such favorable government initiatives and funding to significantly propel precision medicine market size, especially in the United States.

Browse key industry insights spread across 110 pages with 64 market data tables & 09 figures & charts from the report Precision Medicine Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/precision-medicine-market

With favorable regulatory scenario in the country, it is quite overt that U.S. will be lucrative growth ground for precision medicine industry expansion. In fact, reports claim that in 2016, U.S. accounted for largest share in global precision medicine industry. Reports claim that, several U.S. based industry leaders are betting big on precision medicine as the future of healthcare. Recently in July, renowned social media tycoon Mark Zuckerberg and his wife Dr. Priscilla Chan donated USD 10 million to the University of California-San Francisco’s precision medicine laboratory. With such growing support toward development of new technologies across the region, U.S. precision medicine industry is expected to witness remarkable gains in the coming years.

Make an inquiry for purchasing this report - https://www.gminsights.com/inquiry-before-buying/671

According to a report from the Tufts Center for the study of Drug Development, the investment in precision medicine industry has nearly doubled in past 5-7 years. However, despite this growth in investment, the excessive cost associated with precision medicine, on account of inflated research and development process is expected to be a major roadblock for the expansion of precision medicine market size. Moreover, industry analysts predict that because precision medicine treatment can possibly only be used for a small subset of patients, the return on investment will be potentially low. While acknowledging that precision medicine is relatively expensive, some research models predict that the cost will actually go down with emerging partnerships between precision medicine market players, drug companies, and tech-giants.

For instance, in 2016, Google and Stanford Medicine collaborated to develop clinical genomics services. Reportedly, Stanford will leverage on Google Genomics and cloud computing technology to improve precision medicine and patient care. Industry experts further expect such moves to significantly improve the quality, accessibility, and affordability of precision medicine in the long run. In the ensuing years, precision medicine market is likely to witness interesting developments and is all set to become the next big thing in the healthcare domain. Given the projected demand for personalized medicine across the established economies, analysts forecast precision medicine industry to accomplish commendable growth in the forthcoming years.

Browse Related Reports:

Pharmacovigilance Market Size By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By Service Provider (In-house, Contract outsourcing) Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Spain, Italy, France, China, Japan, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Qatar), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

https://www.gminsights.com/industry-analysis/pharmacovigilance-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.